Anesthesiology, Pain Medicine · Cuyahoga Falls, OH
NPI
1881866671
Since 2008
Specialty
Anesthesiology, Pain Medicine
Code 207LP2900X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1900 23rd St.
Cuyahoga Falls, OH, 44223
Phone (330) 971-7246
Groups this clinician bills Medicare through
Medicare paid, 2024
$69K
1,053 services
Medicare patients, 2024
292
Average age 73
Drug cost, 2024
$327K
3,967 prescriptions
Company payments, 2025
$62.87
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James T Sable Jr. was code 99214 (office e&m - established), 301 times for 188 patients. In total James T Sable Jr. billed 1,053 services in 43 codes, and Medicare paid $69K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-11-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 301 | 188 | $65.03 | $20K |
| 99213 Office E&M - Established | Facility | 78 | 57 | $39.56 | $3,086 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 73 | 62 | $12.40 | $905 |
| 99232 Hospital E&M - Subsequent | Facility | 63 | 24 | $58.90 | $3,711 |
| 64493 Nerve Block Injection - Back | Facility | 54 | 29 | $99.09 | $5,351 |
| 99204 Office E&M - New | Facility | 51 | 51 | $93.60 | $4,774 |
| 64494 Nerve Block Injection - Back | Facility | 49 | 26 | $55.77 | $2,733 |
| 99152 Anesthesia | Facility | 45 | 39 | $9.29 | $418 |
| 20611 Joint Injection | Facility | 33 | 28 | $51.58 | $1,702 |
| 64635 Destruction by Neurolytic Agent - Back | Facility | 31 | 31 | $212.38 | $6,584 |
| 64636 Destruction by Neurolytic Agent - Back | Facility | 29 | 29 | $65.47 | $1,899 |
| 64483 Nerve Block Injection - Back | Facility | 27 | 24 | $88.78 | $2,397 |
| 76942 Ultrasound - Nonspecific | Facility | 22 | 21 | $21.29 | $468 |
| 99223 Hospital E&M - Initial | Facility | 21 | 21 | $131.67 | $2,765 |
| 62323 Nerve Block Injection - Back | Facility | 20 | 19 | $67.91 | $1,358 |
By year: 2022 $74K for 1,013 services; 2023 $60K for 886 services; 2024 $69K for 1,053 services.
Medicare prescription drug claims, 2024
In 2024, the drug James T Sable Jr. prescribed most often to Medicare patients was Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen), with 591 prescriptions and refills. In total James T Sable Jr. wrote 3,967 Medicare prescriptions that cost $327K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 591 | 591 | 210 | $12K |
| Buprenorphine Generic | 488 | 492 | 154 | $120K |
| Gabapentin Generic | 471 | 658 | 188 | $5,221 |
| Tizanidine Hcl Generic | 411 | 497 | 150 | $2,330 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 405 | 405 | 154 | $6,748 |
| Pregabalin Generic | 342 | 411 | 129 | $7,867 |
| Tramadol Hcl Generic | 280 | 280 | 81 | $2,548 |
| Belbuca Buprenorphine Hcl | 96 | 96 | 29 | $70K |
| Topiramate Generic | 94 | 149 | 42 | $697 |
| Baclofen Generic | 90 | 112 | 38 | $737 |
| Oxycodone Hcl Generic | 82 | 82 | 36 | $1,075 |
| Duloxetine Hcl Generic | 65 | 119 | 26 | $3,312 |
| Cyclobenzaprine Hcl Generic | 59 | 73 | 27 | $541 |
| Meloxicam Generic | 51 | 55 | 18 | $41.65 |
| Diclofenac Sodium Generic | 49 | 55 | 28 | $2,200 |
Brand drugs: 272 claims; generic drugs: 3,695 claims; opioid claims: 2,085.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James T Sable Jr. $62.87 ($62.87 in general payments such as food, travel and fees) from 3 companies. The largest payer was Pfizer Inc. with $29.15.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.